March 1993
Advocate;3/23/93, Issue 625, p22
Reports that about 200 people blocked entrances at the U.S. headquarters of the Swiss pharmaceutical firm Hoffmann-La Roche Inc. in Nutley, New Jersey. Claim that the company was stalling development of a promising AIDS drug until the federal government agrees to subsidize the research.


Related Articles

  • Roche Kicks Off Review for Xenical. McMains, Andrew // Adweek Western Edition;04/17/2000, Vol. 50 Issue 16, p86 

    Focuses on a review of Xenical advertising account launched by pharmaceutical company Roche Laboratories in 2000. Advertising spending of the company in 1999; Factor affecting the sales of the drug; Features of the campaign.

  • WOLFE: STRICTER CONTROL OF DTC NEEDED. Dickinson, James G. // Medical Marketing & Media;Apr2002, Vol. 37 Issue 4, p34 

    Reports developments related to direct-to-consumer advertising of drugs in the U.S. as of April 2002. Increase in the direct-to-consumer promotions; Failure of Hoffmann-LaRoche Inc. to include statements of side effects on the Xeloda advertisement; Preference of drug companies to use network...

  • Tamiflu radio ad misleading: DDMAC.  // Medical Marketing & Media;Aug2002, Vol. 37 Issue 8, p34 

    Reports that the U.S. Food and Drug Administration has ordered Hoffman-LaRoche Inc. to stop running a radio direct-to-consumer advertising for its flu drug Tamiflu.

  • Hoffman-La Roche: Employee cafeteria combines lowfat meals.  // FoodService Director;09/15/97, Vol. 10 Issue 9, p6 

    Reports why Hoffman-La Roche, the international pharmaceutical giant based in Nutley, New Jersey, is planning to offer a diet plan for its employees. Designing of breakfast and lunch menus for the diet plan; Hoffman-La Roche expecting government approval for Zencal.

  • Company.  // Pharmaceutical Executive;Oct99, Vol. 19 Issue 10, p150 

    Presents news briefs on the activities of pharmaceutical companies. Commendation given to Hoffmann-La Roche company for its employment practices; Collaboration agreement between SmithKline Beecham company and ImmunoGen company; Facility opened by Almedica International company in Allendale, New...

  • Repositioning the Human Resource Function at Hoffmann-LaRoche. Rubino, Alan L. // Human Resource Planning;1994, Vol. 17 Issue 2, p45 

    This article examines the repositioning process adopted by the pharmaceutical company Hoffmann La-Roche Inc., in managing its human resources. The role of the human resource function is changing radically in leading companies, in response to new business challenges and significant opportunities...

  • Women Under-Represented In Pharma Senior Offices. P., Shankar // njbiz;6/16/2008, Vol. 21 Issue 25, p17 

    The article reports on the under-representation of women in middle and senior management roles at life-sciences companies in the U.S. and Europe. A study conducted by the Health Businesswomen's Association from 2002 until 2006 shows that an average of 35% of such roles are taken by women...

  • Firms seek new indications for drugs despite easing of off-label promotion rules.  // Medical Marketing & Media;Oct99, Vol. 34 Issue 10, p25 

    Reports on drug manufacturers' search of additional indications for currently marketed drugs in the United States. Roche Laboratories' filing for a colon cancer indication for its anti-breast cancer drug Xeloda; Eli Lilly & Co.'s plan to expand use of the drug Evista in the treatment of...

  • Latelines.  // Drug Topics;1/17/2000, Vol. 144 Issue 2, p7 

    Presents news briefs on to the pharmaceutical industry in the United States (US) as of January 17, 2000. Increase in spending of shoppers in 1999 for holiday gifts; Approval of the US Food and Drug Administration for Tamiflu, a medication manufactured by Hoffmann-La Roche for influenza; Request...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics